Transcriptome sequencing of tumor lesions from the same patient after neoadjuvant hormonal therapy (NHT) revealed that NHT treatment significantly inhibited AR pathway activities in adenocarcinoma, but had less effects on AR signaling activities in IDC-P. The gene discussed is AR; the disease is adenocarcinoma.